Related Experiment Video
Updated: Oct 2, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Role of TRPC6 in kidney damage after acute ischemic kidney injury
Zhihuang Zheng1,2,3, Dmitry Tsvetkov4,5,6, Theda Ulrike Patricia Bartolomaeus2,7
1Department of Nephrology/Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Abstract:
Transient receptor potential channel subfamily C, member 6 (TRPC6), a non-selective cation channel that controls influx of Ca2+ and other monovalent cations into cells, is widely expressed in the kidney. TRPC6 gene variations have been linked to chronic kidney disease but its role in acute kidney injury (AKI) is unknown. Here we aimed to investigate the putative role of TRPC6 channels in AKI. We used Trpc6-/- mice and pharmacological blockade (SH045 and BI-749327), to evaluate short-term AKI outcomes. Here, we demonstrate that neither Trpc6 deficiency nor pharmacological inhibition of TRPC6 influences the short-term outcomes of AKI. Serum markers, renal expression of epithelial damage markers, tubular injury, and renal inflammatory response assessed by the histological analysis were similar in wild-type mice compared to Trpc6-/- mice as well as in vehicle-treated versus SH045- or BI-749327-treated mice. In addition, we also found no effect of TRPC6 modulation on renal arterial myogenic tone by using blockers to perfuse isolated kidneys. Therefore, we conclude that TRPC6 does not play a role in the acute phase of AKI. Our results may have clinical implications for safety and health of humans with TRPC6 gene variations, with respect to mutated TRPC6 channels in the response of the kidney to acute ischemic stimuli.
Insights
Transient Receptor Potential channel C6 (TRPC6) does not impact acute kidney injury (AKI) outcomes. TRPC6 deficiency or inhibition did not alter kidney damage markers or inflammation in mice during short-term AKI.
Area of Science:
- Nephrology
- Molecular Biology
- Physiology
Background:
- Transient Receptor Potential channel C6 (TRPC6) is a kidney-expressed cation channel.
- TRPC6 gene variations are linked to chronic kidney disease.
- The role of TRPC6 in acute kidney injury (AKI) remains unclear.
Purpose of the Study:
- To investigate the role of TRPC6 channels in the acute phase of kidney injury.
- To evaluate the effects of TRPC6 deficiency and pharmacological inhibition on AKI outcomes.
Main Methods:
- Utilized Trpc6 knockout (Trpc6-/-) mice.
- Employed pharmacological TRPC6 blockers (SH045 and BI-749327).
- Assessed serum markers, renal epithelial damage, tubular injury, inflammation, and renal arterial myogenic tone.
Main Results:
- Trpc6 deficiency did not affect short-term AKI outcomes.
- Pharmacological TRPC6 inhibition showed no influence on AKI markers.
- No significant differences were observed in renal damage, inflammation, or myogenic tone between groups.
Conclusions:
- TRPC6 does not play a significant role in the acute phase of kidney injury.
- TRPC6 modulation does not impact the kidney's response to acute ischemic stimuli.
- Findings suggest potential implications for human TRPC6 gene variations in AKI context.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

